Pharmafile Logo
Pharmafocus logo
Advanced Search

ucla

Showing 6 posts of 6 posts found.

Merck and UCLA find new COVID-19 treatment candidate

March 25, 2021
COVID-19, Merck, berzosertib, covid-19 treatment, ucla

Merck (MSD in the UK), the UCLA, and other universities from the US and Germany have uncovered a compound that …

News

Xencor and UCLA TDG partner to develop therapeutic antibodies

February 25, 2021
Xencor, ucla

Xencor and UCLA Technology Development Group (UCLA TDG) have announced an agreement to develop novel therapeutic antibodies, pairing novel targets …

News
371628984_a662993bf6_z

Antibiotic combinations could help in fight against antimicrobial resistance

September 4, 2018
Manufacturing and Production AMR, Antibiotics, antibiotic resistance, e coli, ucla

Antimicrobial resistance (AMR) could be tackled by giving people a combination of antibiotic drugs that are no longer effective on …

News
three_syringes

New step in fight against antibiotic-resistant bacteria

February 8, 2017
Research and Development antibiotic, antibiotic resistance, antibiotic-resistance, ucla

There is an increasing number of stories circulating regarding the threat posed by antibiotic-resistant bacteria, only last week four kilometres …

News

Bristol-Myers Squibb chooses UCLA as latest research partner

December 14, 2015
Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, University of California Los Angeles, rare malignancies, ucla

Pharma firm Bristol-Myers Squibb is entered into a new collaboration agreement with the University of California Los Angeles (UCLA) as …

News
Map image

Twitter useful for tracking HIV outbreaks

March 5, 2014
Medical Communications, Sales and Marketing AIDS, HIV, Twitter, digital, flu, ucla, virus, wells

A study by UCLA researchers has shown that Twitter and social media can be used as a practical real-time tool …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024